Thesis project: Design of Potent Monovalent LecA Ligands and Stealth Carbohydrate Prodrugs for Future Anti-Biofilm Strategies

Laboratories: CERMAV & IBS - 01/11/2023 - 31/10/2026

Thesis project holders: Sami HALILA and Yvan CASPAR
Young thesis researcher: Bastian BOHRER

Abstract: Pseudomonas aeruginosa is a priority pathogen that builds biofilms, shielding it from antibiotics and turning infections chronic. Rather than killing it, this project disarms it by blocking LecA, the protein the bacterium uses to grip host cells. Two advances were made: a new family of small sugar molecules yielded one of the most potent single-unit LecA binders reported to date; and that molecule was then fitted with a chemical mask only P. aeruginosa can remove, using the very enzyme it deploys against antibiotics. The inhibitor is released only at the infection site — a route to anti-biofilm drugs that do not drive resistance.

schema-bohrer

Publication: Hydroxybenzoic Galactosides as High-Affinity Monovalent Pseudomonas aeruginosa LecA Ligands: Substitution-Pattern Effects and Structural Basis of Recognition. B. Bohrer, T. Arnaud, A. Imberty, S. Halila. ChemMedChem, Submitted, under review (2026).

Stealth Carbohydrates: β-Lactamase-Activated Cephalosporin Prodrug for Targeted LecA Inhibition in Pseudomonas aeruginosa Biofilms. B. Bohrer, C. Bougault, A. Imberty, S. Elsen, E. Faudry, Y. Caspar, S. Halila. Manuscript in preparation (2026).
Published on  November 17, 2026
Updated on November 17, 2026